Dynamic Code is undergoing changes in Norway

Dynamic Code signs two new agreements, changing its presence in Norway. A collaboration is now being entered into with one of Norway's largest digital healthcare providers, Nettlegevakt, and the digital pharmacy Apotera.

Dynamic Code has previously existed in Norway via a Norwegian online store and a digital healthcare provider. Now Dynamic Code is shifting its operations with two strategically important agreements, and thereby increasing its presence in Norway.

"The pandemic has shown that self-testing is here to stay. Via our digital flow, Nettlegevakt can meet the customer's needs more precisely and Apotera can sell a complete set and not just a single product. These two important strategic partners help us to reach more individuals, and thereby increase our pace in Norway and develop our concept in the Norwegian market," says Louise Nylén, CEO of Dynamic Code.

Nettlegevakt was integrated into Dynamic Code's digital flow
The Norwegian digital healthcare provider Nettlegevakt will initially refer patients with suspected bacterial vaginosis or Candida to Dynamic Code's self-testing kit as part of the diagnostic process and any further treatment. Nettlegevakt will see patients who have purchased self-testing kits via dynamiccode.no in order to make a diagnosis and offer treatment. Nettlegevakt is included in Dynamic Code's digital flow, which means that the processing of referrals and test results is integrated into Nettlegevakt's system.

"The agreement with Dynamic Code means that we can offer even more self-testing kits in the Norwegian market. We believe that the combination of easy access, good tests and quick results means that more people will choose to test themselves and get the right treatment," says Thomas Bergqvist, doctor and founder of Nettlegevakt.

Apotera becomes a reseller of self-testing kits
The agreement with Apotera, a fast-growing digital pharmacy in Norway, means they will be the resellers for around fifteen products. The

"Dynamic Code's self-testing kits allow us to help our customers take control of their health by enabling diagnosis before contact with a doctor. Seeking treatment with the right diagnosis significantly streamlines healthcare," says Patrick Hjetland, Co-founder & CEO at Apotera.